The Dubai Health Authority’s Thalassemia Centre recently completed renovation of its triage and preparatory area.
The centre organised a celebration to mark the completion of the project, which will further help enhance the level of care provided to thalassemia patients.
The renovation has been sponsored by Dr. Ayman Al Baya’a, Chairman of Al Wasl International Group Advocates & Legal consultants, and Ambassador of Goodwill, who was present at the celebration along with patients and health care professionals from the Centre.
Dr Khawla Belhoul, Director of the DHA’s Thalassemia Centre, thanked Al Wasl International Group for this contribution. She said: “Thalassemia patients need the support of the community and we are thankful to all those individuals and organisations that have helped contribute towards the care of thalassemia patients.”
Thalassemia occurs when there is a defect in the gene that controls production of proteins in the hemoglobin, which can lead to anemias. Thalassemia can be managed by following treatment plans, monthly blood transfusions, folate supplements. The only curative treatment for Thalassemia is a bone marrow stem cell transplant, but only a small proportion of patients are able to find a good donor match, and the procedure is risky.
The Dubai Thalassemia Centre has been operational since 1989, and is the first ambulatory centre worldwide outside the USA to be awarded Joint Commission International (JCI) accreditation.